Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Health Rehabilitation for Heart Disease (RESILIENT Trial)
N/A
Waitlist Available
Led By John Dodson, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥65
Capable of self-consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
RESILIENT Trial Summary
This trial aims to see if a mobile health program can help improve heart function in older adults compared to traditional care. A total of 400 patients will be enrolled and followed for at least 3 months.
Who is the study for?
This trial is for older adults aged 65 or above who have been hospitalized for ischemic heart disease (like a heart attack, stent placement, or bypass surgery) recently. They must be able to walk, give consent themselves, and use mobile health technology in English or Spanish. People with severe movement disorders, very short life expectancy, severe cognitive issues, certain recent surgeries or conditions that limit walking are not eligible.Check my eligibility
What is being tested?
The RESILIENT study tests if a mobile health cardiac rehab program (mHealth-CR) can improve the physical function of older adults after hospitalization due to heart disease better than standard care. Participants will either receive mHealth-CR or usual care in a ratio of 3:1 by random selection.See study design
What are the potential side effects?
Since this trial involves non-drug interventions like using mobile health technology for rehabilitation exercises at home rather than medication side effects may include discomfort from exercise and potential injury if exercises are performed improperly.
RESILIENT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Select...
I am able to understand and agree to the study on my own.
RESILIENT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in 6-minute walking distance (6MWD)
Secondary outcome measures
Change in Activities of Daily Living (ADLs)
Change in Basic Activities of Daily Living (BADLs)
Death
+4 moreRESILIENT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: mHealth-CRExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,321 Total Patients Enrolled
21 Trials studying Coronary Artery Disease
14,778 Patients Enrolled for Coronary Artery Disease
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,179 Total Patients Enrolled
10 Trials studying Coronary Artery Disease
11,491 Patients Enrolled for Coronary Artery Disease
John Dodson, MDPrincipal InvestigatorNew York Langone Health
3 Previous Clinical Trials
41 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a left ventricular assist device.I can follow study instructions and perform tasks like a 6-minute walk test.The doctors think there are other safety concerns or you might not follow the study rules.I have significant memory or thinking problems.I have severe joint pain or had a joint replacement recently.I regularly use a walker to move around.I completed a heart rehab program in the last 3 months.I cannot use mobile health apps in English or Spanish.I have a groin injury from a heart procedure that stops me from walking quickly.Doctors think you may live for less than 3 months.You are currently on the waiting list for a heart transplant.You are in prison.I have Parkinson's disease or a similar movement disorder.I am 65 years old or older.I am currently in the hospital or was hospitalized in the last 2 weeks for a heart attack or heart surgery.I am able to understand and agree to the study on my own.I cannot walk by myself.
Research Study Groups:
This trial has the following groups:- Group 1: mHealth-CR
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many subjects are partaking in this investigation?
"Indeed, the clinicaltrials.gov website reveals that this ongoing medical trial is currently searching for 400 volunteers to be recruited from 1 location. This research was initially posted on September 9th 2020 and updated more recently on April 5th 2022."
Answered by AI
Are there still openings for volunteers within this clinical trial?
"Affirmative. Clinicaltrials.gov offers evidence that this clinical trial, initially posted on September 1st 2020, is still actively recruiting patients. 400 individuals need to be enrolled across a single medical facility."
Answered by AI
Am I eligible to join the experiment?
"Aspiring participants of this medical trial should have ischemic heart disease, with an age range between 65 and 110 years old. The study hopes to recruit around 400 qualified candidates."
Answered by AI
Does this investigative research accept geriatric participants?
"This study seeks to enrol individuals that are between 65 and 110 years old."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger